Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00989157 · ClinicalTrials.gov registry record · Phase 3
Effects of Gastric Bypass on Blood Levels of Duloxetine
A Phase 3 study of Bariatric Surgery, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00989157: Completed Phase 3 study of Bariatric Surgery, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
NCT00989157 is a Phase 3 study of Bariatric Surgery that has completed, run by Neuropsychiatric Research Institute, Fargo, North Dakota. The registered enrollment target is 20 participants, below the 98-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00989157, a Phase 3 study of Bariatric Surgery, has completed, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Primary Outcome
The difference, if any, in the pharmacokinetics parameters (Cmax) of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for BMI, age and gender.
Conditions Studied
Interventions
- DRUG Duloxetine
Study Locations (1)
North Dakota
- Neuropsychiatric Research Institute - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
What the finished NCT00989157 record still lists
NCT00989157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 98-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Bariatric Surgery appearing as the primary indexed condition, and to 1 intervention - of which Duloxetine is the first listed.
NCT00989157 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT00989157 about?
NCT00989157 is a clinical study titled "Effects of Gastric Bypass on Blood Levels of Duloxetine". This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
What is the current status of trial NCT00989157?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2012-11.
What conditions does trial NCT00989157 study?
This clinical trial studies the following conditions: Bariatric Surgery.
What interventions are being tested in trial NCT00989157?
The interventions under investigation include: Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00989157?
This trial is sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00989157 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00989157's enrollment target sits among peer trials
20 16th of 15 the lowest of 15 other Bariatric Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
RECRUITING · Phase 1
-
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
RECRUITING · Phase 2
-
2024 Tirzepatide-Bariatric Surgery
RECRUITING · Phase 4
-
Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery
RECRUITING · NA
-
Simethicone as Part of ERAS in Bariatric Surgery Patients
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia